Soliqua 100/33 is a combination medication used to treat type 2 diabetes in adults. It combines two powerful drugs, insulin glargine and lixisenatide, to help control blood sugar levels. Insulin glargine is a long-acting insulin that helps regulate blood sugar throughout the day, while lixisenatide is a glucagon-like peptide-1 receptor agonist that helps stimulate insulin production and decrease glucose production by the liver.

This medication is typically prescribed for patients who have not achieved adequate blood sugar control with other diabetes medications. Soliqua 100/33 is administered once daily, usually within an hour before the first meal of the day. It is important to follow your healthcare provider’s instructions on how to properly inject the medication and monitor your blood sugar levels regularly.

As with any medication, there are potential side effects to be aware of. Common side effects of Soliqua 100/33 may include nausea, vomiting, diarrhea, headache, and hypoglycemia (low blood sugar). It is important to report any severe or persistent side effects to your healthcare provider.

Before starting Soliqua 100/33, it is important to discuss your medical history and any other medications you are taking with your healthcare provider. They can help determine if this medication is the right choice for you and adjust your dosage as needed.

Overall, Soliqua 100/33 can be an effective treatment option for individuals with type 2 diabetes who require additional blood sugar control. By working closely with your healthcare provider and following their recommendations, you can help manage your diabetes and improve your overall health and well-being.